Assessment of Acute Myeloid Leukemia for Expression of Tryptase and CD123 by Immunohistochemistry

被引：0
|
作者：
Hatooglu, Medina [1 ]
O'Malley, Dennis [2 ]
机构：
[1] NeoGen Labs Inc, Aliso Viejo, CA USA
[2] NeoGen Labs Inc, Dana Point, CA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1387
引用
收藏
页码：1307 / 1308
页数：2
相关论文
共 50 条
  • [31] CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo
    G Li
    X Li
    H Wu
    X Yang
    Y Zhang
    L Chen
    X Wu
    L Cui
    L Wu
    J Luo
    X Y Liu
    Blood Cancer Journal, 2014, 4 : e194 - e194
  • [32] CD123 (IL3-R) and CD116 (GM-CSF-R) expression in acute myeloid leukemia.
    Donnard, M
    Trimoreau, F
    Pascal, T
    Nathalie, G
    Luc, FJ
    Bordessoule, D
    Jean, F
    BLOOD, 2002, 100 (11) : 248B - 248B
  • [33] CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo
    Li, G.
    Li, X.
    Wu, H.
    Yang, X.
    Zhang, Y.
    Chen, L.
    Wu, X.
    Cui, L.
    Wu, L.
    Luo, J.
    Liu, X. Y.
    BLOOD CANCER JOURNAL, 2014, 4 : e194 - e194
  • [34] Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia
    Ji, Rui-Jin
    Cao, Guo-Hua
    Zhao, Wei-Qiang
    Wang, Mu-Yao
    Gao, Pan
    Zhang, Yi-Zhou
    Wang, Xue-Bin
    Qiu, Hou-Yuan
    Chen, Di-Di
    Tong, Xiao-Han
    Duan, Min
    Yin, Hao
    Zhang, Ying
    CELL STEM CELL, 2024, 31 (11)
  • [35] Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
    Mayumi Sugita
    Roman Galetto
    Hongliang Zong
    Nathan Ewing-Crystal
    Vicenta Trujillo-Alonso
    Nuria Mencia-Trinchant
    Winnie Yip
    Stephanie Filipe
    Celine Lebuhotel
    Agnès Gouble
    Duane C. Hassane
    Julianne Smith
    Gail J. Roboz
    Monica L. Guzman
    Nature Communications, 13
  • [36] CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia
    Xu, Shilin
    Zhang, Meichen
    Fang, Xiaocui
    Hu, Xuechun
    Xing, Haiyan
    Yang, Yanlian
    Meng, Jie
    Wen, Tao
    Liu, Jian
    Wang, Jianxiang
    Wang, Chen
    Xu, Haiyan
    ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (34) : 38584 - 38593
  • [37] Allogenic T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML)
    Galetto, Roman
    Lebuhotel, Celine
    Gouble, Agnes
    Schiffer-Mannioui, Cecile
    Smith, Julianne
    BLOOD, 2014, 124 (21)
  • [38] Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
    Sugita, Mayumi
    Galetto, Roman
    Zong, Hongliang
    Ewing-Crystal, Nathan
    Trujillo-Alonso, Vicenta
    Mencia-Trinchant, Nuria
    Yip, Winnie
    Filipe, Stephanie
    Lebuhotel, Celine
    Gouble, Agnes
    Hassane, Duane C.
    Smith, Julianne
    Roboz, Gail J.
    Guzman, Monica L.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [39] Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia
    Kandeel, Eman Z.
    Madney, Youssef
    Eldin, Dalia Negm
    Shafik, Nevine F.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2021, 118
  • [40] CD123 Expression in Philadelphia Chromosome-like B Acute Lymphoblastic Leukemia/Lymphoma
    Lyapichev, Kirill A.
    Sukswai, Narittee
    Angelova, Evgeniya
    Kersh, Marian J.
    Pierce, Sherry
    Konopleva, Marina
    Jain, Nitin
    Jabbour, Elias J.
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Medeiros, L. Jeffrey
    Khoury, Joseph D.
    Konoplev, Sergej
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : E317 - E320
12345